Racial differences in clinical and pathological associations with PhIP-DNA adducts in prostate
โ Scribed by Deliang Tang; Jason J. Liu; Cathryn H. Bock; Christine Neslund-Dudas; Andrew Rundle; Adnan T. Savera; James J. Yang; Nora L. Nock; Benjamin A. Rybicki
- Book ID
- 111700505
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 173 KB
- Volume
- 121
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Prostate-specific antigen (psa) is a good objective measure of tumor cell burden or virulence of disease, or both, in prostate cancer. many differences between whites and african americans (aa) have been noted in prostate cancer in the united states, including a poorer outcome in afr
Background. There are few published data on stage-specific prostate cancer incidence rates in United States black patients versus white patients, and there are no data comparing treatment received by black versus white patients with prostate cancer. Methods. Using data from a population-based cance